TC BioPharm (Holdings) PLC (TCBP)
1.42
-0.04
(-2.74%)
USD |
NASDAQ |
May 06, 16:00
1.41
-0.01
(-0.70%)
After-Hours: 19:25
TC BioPharm SG&A Expense (Quarterly)
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 1.586M |
| September 30, 2021 | 1.444M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.733M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.733M
Minimum
Dec 2020
1.586M
Maximum
Dec 2021
1.254M
Average
1.444M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 16.88M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 1.597M |
| Autolus Therapeutics PLC | 15.73M |
| Mereo BioPharma Group PLC | -- |